MRRSE has announced the addition of the “Ablation Technologies Market (Applications: Cardiovascular, Gynecology, Pain Management, Oncology, Urology, Ophthalmology; Technologies: Radiofrequency, Light/Laser, Electrical, Ultrasound, Microwave, Cryotherapy) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 - 2020” report to their offering.

1. Ablation Technologies Market - Detailed Analysis of Current
Industry Figures with Forecasts Growth By 2020
Report Description
Ablation technologies based surgeries are minimally invasive
and are emerging as an alternative to primitive invasive
surgical procedures. Ablation involves either complete

2. destruction or removal of abnormal tissue with the aim to
cure the disease. Ablation technologies market can be
segmented into two prominent categories namely thermal
ablation and non-thermal ablation. The thermal ablation
technology encompasses radiofrequency, microwave,
ultrasound, hydrothermal, electrical and light/laser
technologies whereas, cryoablation technology falls under
non-thermal ablation category. The principal advantage of
these procedures over surgery is short recovery time,
minimum invasion, low risk of infection, lesser blood loss,
and shorter hospital stays. Ablation technologies have
applications in various clinical areas such as cancer, cardiac,
ophthalmology, urology, gynecology and orthopedics. The
report also provides the compound annual growth rate (CAGR

3. %) for each of the segments for the forecast period 2014-
2020, while market size estimations have been made
considering 2012 and 2013 as base years.
Request a Sample Copy of the Report @
http://www.mrrse.com/sample/1275
The global market for ablation technologies market has been
studied on the basis of application type and technologies
type. The application segment has been sub-segmented into
these prominent categories namely cardiovascular,
gynecology, pain management, oncology, urology,
ophthalmology and others. Whereas, the ablation technologies
market has been fragmented into radiofrequency, light/laser,

4. electrical, ultrasound, microwave, cryotherapy and others. RF
ablation is the most established device type, but ultrasound
ablation and cryoablation are growing rapidly owing to
advantages associated such as minimal damage to associated
tissues among others. Cryoablation devices are the only kind
of ablation device that can be used to treat prostate cancer.
Urologists and interventional radiologists both use
cryoablation to treat kidney cancer using differing techniques.
As per an analysis by Center for Disease Prevention and
Control (CDC) approximately 5.1 million people face heart
failure every year of which one in nine deaths in 2009 were
primarily due to cardiac arrhythmia. As per WHO projection,
approximately 32 million people are living with some form
cancer causing 8 million deaths across the world which

5. clearly depicts scope of opportunities for players operating in
the ablation technologies market.
Inquiry on this report @ http://www.mrrse.com/enquiry/1275
Other prominent drivers to the global ablation technologies
market include increasing adoption of ablation techniques and
devices in cosmetics such as varicose vein treatment,
psoriasis among others are key areas of opportunities in
developing economic countries. Restraints to the ablation
technologies market include disparities in the reimbursement
scenario across globe along with regulations to curb pricing
pressure which include Affordable Care Act and deployment

6. of Accountable Care Organization especially in developed
economic regions, thus affecting the overall growth and
uptake of the ablation devices. Furthermore, high procedural
cost is main area of concern for companies operating in this
market.
Geographically, North America which includes the United
States and Canada continues to be a leading market in
ablation technologies. The United States market accounts for
major contribution owing to larger population base, larger
penetration of healthcare services and wider acceptance of
these novel technologies. Although Canada’s contribution in
North America revenue is significantly low as compared to
the United States yet there has been a shift in trend towards

7. adoption of novel ablation technologies such as radiation and
microwave ablation therapies in past couple of years.
Pertaining to the adoption rate, the market for ablation
products is likely to grow exponentially in forthcoming years.
An estimated 191,300 new cases of cancer and 76,600 deaths
from cancer will occur in Canada in 2014 accounting for 30%
of overall deaths. About 52% of all the new cases of cancer
in Canada will include prostate, breast, lung and colorectal
cancers. Companies like Medtronic in 2008, looking at the
untapped opportunities in Canadian market acquired Montreal
based CryoCath Technologies Inc. to form Medtronic’s AF
Solutions division which as of now offers an extensive line of
diagnostic, cryoablation and radiofrequency ablation tools to

8. diagnose and treat a broad spectrum of cardiac
arrhythmias.
Read Complete Report with TOC @
http://www.mrrse.com/ablation-technologies-market
Asia-Pacific region during the forecast is the fastest growing
region owing to larger population base of patients suffering
from cardiovascular, cancer and arthritis and other orthopedic
disorders. Overall drivers to Asia-Pacific market for ablation
technologies include increasing healthcare awareness, rise in
healthcare expenditure and increase in chronic diseases due
to change in lifestyle and food habits. Rest of the World
market is still at nascent stage and is expected to grow

9. considering continuous rise in prevalence rate of
hypertension, cardiovascular and urological diseases.
Some of the key companies operating in this market include
St. Jude Medical, Inc., Bioscience Webster Inc., Medtronic,
Inc., Boston Scientific Corp, Covidien PLC and
Angiodynamics, Inc. among others.
About MRRSE
MRRSE stands for Market Research Reports Search Engine,
the largest online catalog of latest market research reports
based on industries, companies, and countries. MRRSE
sources thousands of industry reports, market statistics, and

10. company profiles from trusted entities and makes them
available at a click. Besides well-known private publishers,
the reports featured on MRRSE typically come from national
statistics agencies, investment agencies, leading media houses,
trade unions, governments, and embassies.
Contact US:
Corporate Office
State Tower
90 State Street, Suite 700
Albany, NY 12207

11. United States
Tel: +1-518-730-0559
Email: sales@mrrse.com